229 229 Pill - white oval, 19mm
Pill with imprint 229 229 is White, Oval and has been identified as Metformin Hydrochloride 1000 mg. It is supplied by Ascend Laboratories, LLC.
Metformin is used in the treatment of Diabetes, Type 2 and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy. Metformin 1000 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 229 229
Metformin Hydrochloride
- Imprint
- 229 229
- Strength
- 1000 mg
- Color
- White
- Size
- 19.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Non-sulfonylureas
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ascend Laboratories, LLC
- Inactive Ingredients
-
corn starch,
povidone,
magnesium stearate,
hypromellose 2910 (15 mPa.s),
magnesium silicate,
titanium dioxide,
polyethylene glycol 6000,
propylene glycol
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 67877-0221 | Ascend Laboratories LLC |
| 00904-6328 (Discontinued) | Major Pharmaceuticals |
Related images for "229 229"
More about metformin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (650)
- Drug images
- Latest FDA alerts (18)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: non-sulfonylureas
- Breastfeeding
Patient resources
- Metformin drug information
- Metformin Extended-Release Suspension
- Metformin Extended-Release Tablets
- Metformin Tablets
- Metformin Oral Solution
Other brands
Glucophage, Glumetza, Glucophage XR, Fortamet, ... +2 more
Professional resources
- MetFORMIN monograph
- Metformin (FDA)
- Metformin Aerosol (FDA)
- Metformin Extended Release Tablet (FDA)
- Metformin Extended Release Tablets (FDA)
- Metformin Oral Solution (FDA)
Other brands
Glucophage, Glumetza, Glucophage XR, Fortamet, Riomet
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
